Compare stocks

Evaluate stocks side by side, to find the best fit for your investment goals.
Bachem Holding AG is a Swiss company specializing in the biotechnology and pharmaceutical industries. It focuses on the development and production of peptides and oligonucleotides for the pharmaceutical and biotech sectors. Its offerings include active pharmaceutical ingredients (APIs) and customized synthesis services. Founded in 1971, Bachem's headquarters is located in Bubendorf, Switzerland, with additional facilities in the United States, Europe, and Asia. The company is known for its extensive expertise in peptide chemistry and its strategic focus on innovation and quality in manufacturing, contributing to its competitive position in the global pharmaceuticals market.
View stock
VS
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
View stock

Stock highlights

Stock comparison highlights
Stock name
Bachem Holding AGJohnson & Johnson
Last price
CHF 83.65$273.20
Currency
CHF
USD
CHF 6.3B$658B
42.1741.49
CHF 1.98$6.58
0.790.21
CHF 0.90$5.28
0.54%1.96%
Sector
HealthHealth
Employees
2,725138,200
Ticker
Fr. BANB$JNJ
Primary listing
XSWXNYSE

Performance

CumulativeRolling yearsLump sum investment

Invest in Fr.BANB or $JNJ on Lightyear

Save on broker fees and invest in 6000+ stocks and funds. When you invest, your capital is at risk.